JP2021529792A5 - - Google Patents
Info
- Publication number
- JP2021529792A5 JP2021529792A5 JP2020573524A JP2020573524A JP2021529792A5 JP 2021529792 A5 JP2021529792 A5 JP 2021529792A5 JP 2020573524 A JP2020573524 A JP 2020573524A JP 2020573524 A JP2020573524 A JP 2020573524A JP 2021529792 A5 JP2021529792 A5 JP 2021529792A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- hydrogen
- clathrate
- prodrug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024094936A JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862690563P | 2018-06-27 | 2018-06-27 | |
| US201862690565P | 2018-06-27 | 2018-06-27 | |
| US62/690,565 | 2018-06-27 | ||
| US62/690,563 | 2018-06-27 | ||
| PCT/US2019/039600 WO2020006296A1 (en) | 2018-06-27 | 2019-06-27 | Proteasome activity enhancing compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094936A Division JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021529792A JP2021529792A (ja) | 2021-11-04 |
| JP2021529792A5 true JP2021529792A5 (https=) | 2022-06-29 |
| JP7561632B2 JP7561632B2 (ja) | 2024-10-04 |
Family
ID=67439356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020573524A Active JP7561632B2 (ja) | 2018-06-27 | 2019-06-27 | プロテアソーム活性増強化合物 |
| JP2024094936A Withdrawn JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024094936A Withdrawn JP2024138260A (ja) | 2018-06-27 | 2024-06-12 | プロテアソーム活性増強化合物 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11560385B2 (https=) |
| EP (1) | EP3814338A1 (https=) |
| JP (2) | JP7561632B2 (https=) |
| KR (1) | KR20210024588A (https=) |
| CN (1) | CN112585132B (https=) |
| AU (1) | AU2019295765B2 (https=) |
| BR (2) | BR112020026580A2 (https=) |
| CA (1) | CA3103954A1 (https=) |
| CL (1) | CL2020003380A1 (https=) |
| CR (1) | CR20200652A (https=) |
| IL (1) | IL279698A (https=) |
| MA (1) | MA53014A (https=) |
| MX (1) | MX2020014082A (https=) |
| PE (1) | PE20211804A1 (https=) |
| PH (1) | PH12020552261A1 (https=) |
| SG (1) | SG11202013026WA (https=) |
| WO (1) | WO2020006296A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102767739B1 (ko) | 2018-06-27 | 2025-02-12 | 브리스톨-마이어스 스큅 컴퍼니 | T 세포 활성화제로서 유용한 치환된 나프티리디논 화합물 |
| MX2021003904A (es) | 2018-10-05 | 2021-10-26 | Annapurna Bio Inc | Compuestos y composiciones para el tratamiento de afecciones asociadas con la actividad del receptor apj. |
| CN111423353B (zh) * | 2020-04-29 | 2022-03-22 | 湖北省生物农药工程研究中心 | 多取代n-芳基吡咯类化合物及其制备方法 |
| CN112142642B (zh) * | 2020-10-15 | 2022-03-04 | 华侨大学 | 一种1,2,3-三取代-5-三氟甲基吡咯衍生物的制备方法 |
| WO2023107597A2 (en) * | 2021-12-08 | 2023-06-15 | Kineta, Inc. | Bicyclic heteroaromatic amide compounds and uses thereof |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1142508A (en) | 1966-04-27 | 1969-02-12 | Whitefin Holding Sa | Pyrrole derivatives |
| GB1154744A (en) | 1966-05-17 | 1969-06-11 | Whitefin Holding Sa | Disubstituted Aminoethanols |
| AP9801302A0 (en) | 1997-07-23 | 2000-01-23 | Pfizer | Indole compounds as anti-inflammatory/analgesic agents.. |
| BR9907228A (pt) | 1998-01-23 | 2000-10-24 | Nat Jewish Med & Res Center | Uso de uma proteìna de choque térmico, processo para proteger um mamìfero de uma doença, formulação para proteger um mamìfero de desenvolver uma doença, uso de uma molécula de ácido nucleico, e processo para prescrever um tratamento para hiper-sensibilidade das vias aéreas ou limitação do fluxo de ar associado com uma doença envolvendo resposta inflamatória |
| US7842470B2 (en) | 2001-10-09 | 2010-11-30 | Oregon Health & Science University | Method for pharmacoperones correction of GnRHR mutant protein misfolding |
| US20060148767A1 (en) | 2001-12-06 | 2006-07-06 | George Cioca | Use of acyl salicylates as heat shock inducers |
| CA2545433A1 (en) | 2003-11-12 | 2005-05-26 | Amicus Therapeutics Inc. | Glucoimidazole and polyhydroxycyclohexenyl amine derivatives to treat gaucher disease |
| EP3782655A1 (en) | 2005-05-17 | 2021-02-24 | Amicus Therapeutics, Inc. | A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives |
| AU2006254796B2 (en) | 2005-06-08 | 2012-08-16 | Amicus Therapeutics, Inc. | Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes |
| US20070207992A1 (en) | 2006-02-21 | 2007-09-06 | Board Of Trustees Of Michigan State University | Geldanamycin derivatives and method of use thereof |
| WO2007131034A1 (en) | 2006-05-03 | 2007-11-15 | The Regents Of The University Of Michigan | Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70 |
| PL2533050T6 (pl) | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
| PL1860101T3 (pl) | 2006-05-24 | 2011-10-31 | Amicus Therapeutics Inc | Sól winianu izofagominy i sposoby zastosowania |
| WO2007150064A2 (en) | 2006-06-23 | 2007-12-27 | Amicus Therapeutics, Inc. | METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE |
| WO2008024978A2 (en) | 2006-08-24 | 2008-02-28 | Serenex, Inc. | Tetrahydroindolone and tetrahydroindazolone derivatives |
| AU2009228765B2 (en) | 2008-03-24 | 2012-05-31 | Novartis Ag | Arylsulfonamide-based matrix metalloprotease inhibitors |
| KR20120117905A (ko) * | 2010-01-28 | 2012-10-24 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 프로테아좀 활성을 향상시키는 조성물 및 방법 |
| HUE044867T2 (hu) | 2011-05-12 | 2019-11-28 | Proteostasis Therapeutics Inc | Proteosztázis szabályzók |
| US9849135B2 (en) * | 2013-01-25 | 2017-12-26 | President And Fellows Of Harvard College | USP14 inhibitors for treating or preventing viral infections |
| AU2014282886A1 (en) | 2013-06-17 | 2015-12-17 | Lupin Limited | Pyrrole derivatives as alpha 7 nAChR modulators |
| FR3008977A1 (fr) | 2013-07-23 | 2015-01-30 | Servier Lab | Nouveaux derives d'isoindoline ou d'isoquinoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2015073528A1 (en) * | 2013-11-12 | 2015-05-21 | Proteostasis Therapeutics, Inc. | Proteasome activity enhancing compounds |
-
2019
- 2019-06-27 JP JP2020573524A patent/JP7561632B2/ja active Active
- 2019-06-27 AU AU2019295765A patent/AU2019295765B2/en not_active Ceased
- 2019-06-27 CR CR20200652A patent/CR20200652A/es unknown
- 2019-06-27 CN CN201980055152.2A patent/CN112585132B/zh active Active
- 2019-06-27 BR BR112020026580-2A patent/BR112020026580A2/pt unknown
- 2019-06-27 WO PCT/US2019/039600 patent/WO2020006296A1/en not_active Ceased
- 2019-06-27 CA CA3103954A patent/CA3103954A1/en active Pending
- 2019-06-27 KR KR1020217002233A patent/KR20210024588A/ko not_active Ceased
- 2019-06-27 MA MA053014A patent/MA53014A/fr unknown
- 2019-06-27 MX MX2020014082A patent/MX2020014082A/es unknown
- 2019-06-27 PE PE2020002159A patent/PE20211804A1/es unknown
- 2019-06-27 SG SG11202013026WA patent/SG11202013026WA/en unknown
- 2019-06-27 BR BR122023023216-0A patent/BR122023023216A2/pt unknown
- 2019-06-27 EP EP19744945.7A patent/EP3814338A1/en not_active Withdrawn
-
2020
- 2020-12-23 CL CL2020003380A patent/CL2020003380A1/es unknown
- 2020-12-23 US US17/133,372 patent/US11560385B2/en active Active
- 2020-12-23 IL IL279698A patent/IL279698A/en unknown
- 2020-12-23 PH PH12020552261A patent/PH12020552261A1/en unknown
-
2022
- 2022-11-18 US US18/057,020 patent/US12319698B2/en active Active
-
2024
- 2024-06-12 JP JP2024094936A patent/JP2024138260A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021529792A5 (https=) | ||
| JP2016531121A5 (https=) | ||
| JP2017132814A5 (https=) | ||
| JP2015522650A5 (https=) | ||
| JP2013531029A5 (https=) | ||
| JP2015527387A5 (https=) | ||
| AR082218A1 (es) | Derivados de arilamida que tienen propiedades antiandrogenicas y proceso de preparacion | |
| JP2017119663A5 (https=) | ||
| JP2017506666A5 (https=) | ||
| RU2016125306A (ru) | Новые пестицидные соединения и применения | |
| JP2017503833A5 (https=) | ||
| JP2009511490A5 (https=) | ||
| JP2009515988A5 (https=) | ||
| JP2016506962A5 (https=) | ||
| TW200643015A (en) | 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives | |
| JP2016505614A5 (https=) | ||
| RU2019130519A (ru) | 4-пиридоновое соединение или его соль, фармацевтическая композиция и содержащий их состав | |
| JP2024532768A5 (https=) | ||
| RU2016118399A (ru) | Производные 4-аминометилбензойной кислоты | |
| JP2016531126A5 (https=) | ||
| JP2019529419A5 (https=) | ||
| MX395406B (es) | Compuestos de piperidinobenzodiazepina con actividad antiproliferativa. | |
| JP2015535847A5 (https=) | ||
| JP2016503778A5 (https=) | ||
| JP2006508979A5 (https=) |